CA Patent

CA3146610A1 — Adhesive drug delivery microparticles and a product comprising thereof

Assigned to AMD Pharma Ltd · Expires 2021-02-25 · 5y expired

What this patent protects

There is provided herein a microparticle for the administration of a pharmaceutical composition at the upper gastrointestinal tract comprising: a core comprising at least one pharmaceutical composition; at least one excipient a first coating layer comprising a bioadhesive materia…

USPTO Abstract

There is provided herein a microparticle for the administration of a pharmaceutical composition at the upper gastrointestinal tract comprising: a core comprising at least one pharmaceutical composition; at least one excipient a first coating layer comprising a bioadhesive material; optionally, a channel forming agent; a film forming polymer; and a cross-linker wherein said cross-linker interacts with said film forming polymer upon exposure to an aqueous environment.

Drugs covered by this patent

Patent Metadata

Patent number
CA3146610A1
Jurisdiction
CA
Classification
—
Expires
2021-02-25
Drug substance claim
No
Drug product claim
No
Assignee
AMD Pharma Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.